Anupam Rasayan India Limited Expands Open Offer Scope by Adding Mates Visa Consultancy Private Limited
Bliss GVS Pharma Limited is currently undergoing an open offer initiated by Anupam Rasayan India Limited, which has been expanded with the addition of Mates Visa Consultancy Private Limited. The modification relates to the ongoing acquisition process as detailed in a recently released addendum to the Public Announcement and Detailed Public Statement.The Open Offer involves the acquisition of up to 2,77,26,848 fully paid-up equity shares of Bliss GVS Pharma Limited from eligible public shareholders. This transaction represents 26.00% of the Expanded Voting Share Capital of the Target Company.
Mates Visa Consultancy Private Limited is being included in this offer process in its capacity as a person acting in concert with Anupam Rasayan India Limited (Acquirer).
Financial Overview of Bliss GVS Pharma Limited
Financial data provided for the period ending March 31, 2026, and prior years reflects the financial standing of Bliss GVS Pharma Limited. Key operational and valuation metrics are detailed below:| Metric | 12 Months Ended Mar 31, 2026 | 12 Months Ended Mar 31, 2025 | 12 Months Ended Mar 31, 2024 |
|---|---|---|---|
| Book Value Per Share | ₹16.90 | ₹21.00 | ₹10.40 |
| Total Worth / Shareholder Funds | 0.0017 | 0.0022 | 0.0010 |
| Dividend (%) | (62.50) | (28.99) | (58.72) |
The company's financial performance metrics, focusing on the period ending March 31, 2026, are summarized as follows:
| Particulars | Audited Revenue from Operations | Audited Total Income/Total Revenue |
|---|---|---|
| Financial Metric | 0.3140 (in Crores) | 0.7942 (in Crores) |
Details of the Open Offer
The open offer aims to acquire a significant portion of the company's shares, and Mates Visa Consultancy Private Limited has been added to the offering structure to participate in the acquisition alongside the Acquirer. The transaction encompasses all corresponding changes related to this addition, as detailed in the addendum documents.BLISSGVS Stock Price Movement
Shares of Bliss GVS Pharma Limited tumbled 3.75% on Friday, shedding ₹18.95 and concluding the day's trading at ₹483.50. The stock traded a total volume of 367,233 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.